The results of transwell chamber and wound healing assays showed that FEZF1-AS1 overexpression significantly enhanced the invasion (Figure 2G–2I) and migration (Figure 3A, 3B) of HCC cells, and downregulation of FEZF1-AS1 caused opposite results. Here, FEZF1 is linked to hepatocellular carcinoma.